Cargando…

Research Progress of Pyroptosis in Fatty Liver Disease

Fatty liver disease (FLD) is a clinical and pathological syndrome characterized by excessive fat deposition and even steatosis in hepatocytes. It has been proven that liver inflammation induced by fat and its derivatives are involved in the pathogenesis of FLD, while the precise mechanism still rema...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Rongxuan, Xue, Weiyue, Wei, Huiting, Fan, Qingqing, Li, Xiang, Qiu, Ye, Cui, Di
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488074/ https://www.ncbi.nlm.nih.gov/pubmed/37685870 http://dx.doi.org/10.3390/ijms241713065

Ejemplares similares

Research Progress of Pyroptosis in Alzheimer’s Disease
por: Xue, Weiyue, et al.
Publicado: (2022)

Exercise Affects the Formation and Recovery of Alcoholic Liver Disease through the IL-6–p47(phox) Oxidative–Stress Axis
por: Cui, Wei, et al.
Publicado: (2022)

Pyroptosis and Insulin Resistance in Metabolic Organs
por: Wei, Huiting, et al.
Publicado: (2022)

Research Progress on Pyroptosis in Hematological Malignancies
por: Lyu, Tianxin, et al.
Publicado: (2023)

Butyrate ameliorates alcoholic fatty liver disease via reducing endotoxemia and inhibiting liver gasdermin D-mediated pyroptosis
por: Zhang, Ting, et al.
Publicado: (2021)

Inflammasome and pyroptosis in autoimmune liver diseases
por: Wang, Jixuan, et al.
Publicado: (2023)

Research Progress on the Mechanism of Acupuncture Treatment for Nonalcoholic Fatty Liver Disease
por: Li, Bai, et al.
Publicado: (2022)

Pattern recognition receptors in the development of nonalcoholic fatty liver disease and progression to hepatocellular carcinoma: An emerging therapeutic strategy
por: Huang, Chen, et al.
Publicado: (2023)

Research progress on the therapeutic effects of polysaccharides on non-alcoholic fatty liver diseases
por: Hu, Yu-long, et al.
Publicado: (2023)

Progress of pyroptosis in acute pancreatitis
por: Li, Hong-Yao, et al.
Publicado: (2021)

Research Progress of Graphene-Based Flexible Humidity Sensor
por: Liang, Rongxuan, et al.
Publicado: (2020)

Bibliometric analysis of global research trends on pyroptosis in lung disease
por: Mo, Wei, et al.
Publicado: (2022)

Research Progress on the Role of Pyroptosis in Myocardial Ischemia-Reperfusion Injury
por: Liu, Yang, et al.
Publicado: (2022)

Pyroptosis and degenerative diseases of the elderly
por: Zhou, Jiamin, et al.
Publicado: (2023)

Research Progress on the Therapeutic Effect of Polysaccharides on Non-Alcoholic Fatty Liver Disease through the Regulation of the Gut–Liver Axis
por: Chen, Xiang, et al.
Publicado: (2022)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Ramai, Daryl, et al.
Publicado: (2021)

Genistein protects against hyperglycemia and fatty liver disease in diet-induced prediabetes mice via activating hepatic insulin signaling pathway
por: Zhang, Nana, et al.
Publicado: (2022)

The Molecular Pathways of Pyroptosis in Atherosclerosis
por: Song, Dan, et al.
Publicado: (2022)

Rapamycin-Loaded mPEG-PLGA Nanoparticles Ameliorate Hepatic Steatosis and Liver Injury in Non-alcoholic Fatty Liver Disease
por: Zhao, Ruifang, et al.
Publicado: (2020)

Pyroptosis in Liver Disease: New Insights into Disease Mechanisms
por: Wu, Jiali, et al.
Publicado: (2019)

Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis
por: Cheng, Quan-Cheng, et al.
Publicado: (2020)

Pyroptosis in the Initiation and Progression of Atherosclerosis
por: Qian, Zhengtao, et al.
Publicado: (2021)

Pyroptosis: mechanisms and diseases
por: Yu, Pian, et al.
Publicado: (2021)

Regulation of Pyroptosis by ncRNA: A Novel Research Direction
por: Gao, Liyuan, et al.
Publicado: (2022)

Citrus maxima and tea regulate AMPK signaling pathway to retard the progress of nonalcoholic fatty liver disease
por: Wen, Shuai, et al.
Publicado: (2022)

Role of Pyroptosis and Ferroptosis in the Progression of Atherosclerotic Plaques
por: Yang, Zhen, et al.
Publicado: (2022)

Intestinal microbiota participates in nonalcoholic fatty liver disease progression by affecting intestinal homeostasis
por: Zhang, Yang, et al.
Publicado: (2021)

Inflammasomes and Pyroptosis of Liver Cells in Liver Fibrosis
por: Gan, Can, et al.
Publicado: (2022)

Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer’s disease
por: Rui, Wenjuan, et al.
Publicado: (2021)

S100A8-Mediated NLRP3 Inflammasome-Dependent Pyroptosis in Macrophages Facilitates Liver Fibrosis Progression
por: Liu, Yan, et al.
Publicado: (2022)

The Role of Autophagy and Pyroptosis in Liver Disorders
por: Zhao, Huijie, et al.
Publicado: (2022)

Attenuating Effects of Dieckol on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Decreasing the NLRP3 Inflammasome and Pyroptosis
por: Oh, Seyeon, et al.
Publicado: (2021)

Disentangling the Progression of Non-alcoholic Fatty Liver Disease in the Human Gut Microbiota
por: Wang, Tianjiao, et al.
Publicado: (2021)

Bibliometric analysis of top 100 cited articles in nonalcoholic fatty liver disease research
por: Zhang, Tong-Shuo, et al.
Publicado: (2016)

Pyroptosis correlates with tumor immunity and prognosis
por: Lou, Xiaoying, et al.
Publicado: (2022)

Jinlida granules ameliorate the high-fat-diet induced liver injury in mice by antagonising hepatocytes pyroptosis
por: Hao, Yuan-yuan, et al.
Publicado: (2022)

Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
por: Fu, Yajie, et al.
Publicado: (2022)

Application of pyroptosis in tumor research (Review)
por: Tan, Jianing, et al.
Publicado: (2023)

The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update
por: Hliwa, Aleksandra, et al.
Publicado: (2021)

Histamine Causes Pyroptosis of Liver by Regulating Gut-Liver Axis in Mice
por: Luo, Qiaoqiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lprt55afd759jr6b53hdqhtc39